Smyth A, Reid H M, Baker A H, McGlynn H
Cancer & Ageing Research Group, School of Biomedical Sciences, University of Ulster, County Londonderry, Northern Ireland.
Int J Radiat Biol. 2007 Jan;83(1):13-25. doi: 10.1080/09553000600983136.
To investigate the potential effects of stable tissue inhibitor of matrix metalloproteinase-1 (TIMP-1) overexpression on DNA damage and cell killing following low-dose gamma-radiation and whether this up-regulation interfered with the activation of the matrix metalloproteinase -2 (MMP-2) and -9 (MMP-9) in a highly metastatic renal carcinoma cell line.
Stable transfections were carried out using the cytomegalovirus expression plasmid pRc/CMV carrying TIMP-1 cDNA and LIPOFECTAMINE reagent. TIMP-1 expression in selected clones was determined by reverse transcriptase-polymerase chain reaction (RT-PCR) and Western blot analysis. Exponentially growing Caki-1 cells were treated with sub lethal doses of ionizing radiation (0- 10Gy) either alone or following stable TIMP-1 transfection. DNA damage was assessed by the Alkaline Comet Assay and cell survival was determined by a clonogenic assay. Caki-1 cell cycle alterations following TIMP-1 transfection were assessed by fluorescence activated cell sorting (FACS) analysis of propidium iodide (PI)-stained cells. The interactions between TIMP-1 and MMP-2 and MMP-9 were analysed 24 hours post-irradiation by means of gelatin zymography.
Three clones with varying degrees of TIMP-1 expression were selected and used for further analysis. TIMP-1 transfected Caki-1 cells displayed significantly higher mean tail moment values (p < 0.05) following irradiation at doses between 5 and 10 Gy relative to that seen with radiation alone. The TIMP-1 radiosensitizing effect was accompanied by large decreases in the survival fraction of the parental Caki-1 cell line and significant increases in the alpha-parameter of the linear-quadratic fit. These effects were directly correlated to the degree of TIMP-1 gene expression detected in the selected clones. Interestingly, elevated levels of TIMP-2 protein were detected in the three TIMP-1 clones compared to TIMP-2 levels present in Caki-l cells. The three clones also displayed marked phenotypic alterations relative to their parental cell line. Significant increases in the percentage of cells arrested in the G2/M phase of the cell cycle were detected in the three clones under normal growth conditions and reduced serum conditions (p < 0.05). When the TIMP-1 clones were assessed for their MMP-2 activity, a marked decrease in the MMP-2 mean protein levels was detected in clone T1-3 following irradiation at doses between 2 and 6 Grays (Gy) (p < 0.01) and clone T1-2 at 2- 5Gy (p < 0.05). MMP-9 activity was differentially affected by ionizing radiation in the three TIMP-1 clones. T1-3 and TI-2 displayed significantly reduced MMP-9 levels at various dose points whereas T1-1 exhibited elevated levels of MMP-9 activity at higher doses of treatment (p < 0.05).
These results demonstrate a dual role for the TIMP-1 overexpression in this renal carcinoma cell line, both as radiosensitizing agents and effectors of MMP-2 and MMP-9 activity.
研究基质金属蛋白酶-1(TIMP-1)稳定过表达对低剂量γ射线照射后DNA损伤和细胞杀伤的潜在影响,以及这种上调是否会干扰高转移性肾癌细胞系中基质金属蛋白酶-2(MMP-2)和-9(MMP-9)的激活。
使用携带TIMP-1 cDNA的巨细胞病毒表达质粒pRc/CMV和脂质体转染试剂进行稳定转染。通过逆转录聚合酶链反应(RT-PCR)和蛋白质免疫印迹分析确定所选克隆中TIMP-1的表达。对数生长期的Caki-1细胞单独或在稳定转染TIMP-1后用亚致死剂量的电离辐射(0 - 10 Gy)处理。通过碱性彗星试验评估DNA损伤,通过克隆形成试验确定细胞存活率。通过对碘化丙啶(PI)染色细胞的荧光激活细胞分选(FACS)分析评估TIMP-1转染后Caki-1细胞周期的变化。照射后24小时通过明胶酶谱法分析TIMP-1与MMP-2和MMP-9之间的相互作用。
选择了三个TIMP-1表达程度不同的克隆用于进一步分析。相对于单独辐射,TIMP-1转染的Caki-1细胞在5至10 Gy剂量照射后显示出显著更高的平均尾矩值(p < 0.05)。TIMP-1的放射增敏作用伴随着亲代Caki-1细胞系存活分数的大幅降低和线性二次拟合α参数的显著增加。这些效应与所选克隆中检测到的TIMP-1基因表达程度直接相关。有趣的是,与Caki-1细胞中存在的TIMP-2水平相比,在三个TIMP-1克隆中检测到TIMP-2蛋白水平升高。这三个克隆相对于其亲代细胞系也表现出明显的表型改变。在正常生长条件和低血清条件下,在这三个克隆中检测到细胞周期G2/M期停滞细胞的百分比显著增加(p < 0.05)。当评估TIMP-1克隆的MMP-2活性时,在2至6格雷(Gy)剂量照射后的克隆T1-3(p < 0.01)和2至5 Gy剂量照射后的克隆T1-2(p < 0.05)中检测到MMP-2平均蛋白水平显著降低。在三个TIMP-1克隆中,MMP-9活性受到电离辐射的不同影响。T1-3和T1-2在各个剂量点显示MMP-9水平显著降低,而T1-1在较高剂量处理时表现出MMP-9活性水平升高(p < 0.05)。
这些结果表明TIMP-1过表达在该肾癌细胞系中具有双重作用,既是放射增敏剂,又是MMP-2和MMP-9活性的调节因子。